Clinical Trials List
Protocol NumberAMT-NR-33
2023-12-01 - 2026-06-30
Phase I/II
ICD-10C79.2
Secondary malignant neoplasm of skin
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.2
Secondary malignant neoplasm of skin
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
18 participants
